Results 241 to 250 of about 240,151 (268)
Some of the next articles are maybe not open access.
Combined Immune Checkpoint Blockade
Seminars in Oncology, 2015There are very few tumor types for which chemotherapy regimens are regularly curative; notable exceptions include testicular cancer and Hodgkin's lymphoma. In both cases combination chemotherapy approaches are required. Thus, it would seem only logical that combination immunotherapy approaches will be required to induce long-term remissions in the ...
openaire +2 more sources
The future of immune checkpoint therapy
Science, 2015Immune checkpoint therapy, which targets regulatory pathways in T cells to enhance antitumor immune responses, has led to important clinical advances and provided a new weapon against cancer. This therapy has elicited durable clinical responses and, in a fraction of patients, long-term remissions where patients exhibit no clinical signs of cancer for ...
Padmanee, Sharma, James P, Allison
openaire +2 more sources
Targeting immune checkpoints in lymphoma
Current Opinion in Hematology, 2015The purpose of this article is to discuss the tumor microenvironment in lymphoma, and to review potential immune targets that are now becoming relevant because of clinical responses seen with the use of immune checkpoint inhibitors.Recent data have shown that cells within the immune microenvironment in lymphoma express programmed death ligand-1 (PD-L1)
openaire +2 more sources
Checkpoints in antibacterial immunity
Research in Immunology, 1998Flesch, I. +3 more
openaire +3 more sources
Immune checkpoint therapy—current perspectives and future directions
Cell, 2023Deblina Raychaudhuri
exaly